Rethinking prenatal supplementation: why format and tolerance are the missing conversation
3 August 2026
No Comments
The Problem with Giant Pills Walk into any pharmacy and the prenatal supplement shelf
Issue: Vol. 37
Building the evidence for responsible food innovation
3 August 2026
No Comments
Innovation in the food sector depends on more than promising ideas. It requires robust
Davide Marchesi – Chair of ILSI Europe’s Microplastics Initiative
3 August 2026
No Comments
What is the main objective of the ILSI Europe Microplastics Initiative, and why is
New Peptides: a challenge in terms of regulatory compliance?
3 August 2026
No Comments
Although peptides have long been present in foods, interest in new peptide-based ingredients has
Insights from the 19th International Scientific Conference on Probiotics, Prebiotics, Gut Microbiota and Health (IPC)
3 August 2026
No Comments
From extracellular vesicles to biotics in space, flatulence-tracking, and ingestible capsules, the 19th
PEER REVIEWED – Acute postprandial gastrointestinal symptom relief with a standardized Perilla frutescens leaf extract: a randomized, double‑blind, placebo‑controlled, cross‑over trial in healthy adults
3 August 2026
No Comments
Introduction Gastrointestinal (GI) discomfort affects a large proportion of the population and can impair
Probiotic Human Study Design and Reporting (PRODARE): improving probiotic research
3 August 2026
No Comments
Introduction Probiotics are defined as live microorganisms that, when administered in adequate amounts, confer
The Blueprint — How Functional Ingredients Pioneered the Digital Decentralized Trial Movement
3 August 2026
No Comments
For decades, the clinical research enterprise operated on the implicit assumption that science required
Beyond Longevity: the new frontier of healthy aging with full spectrum hyaluronans
3 August 2026
No Comments
Healthy aging can no longer be defined simply by longevity. Nowadays, consumers are seeking
How GLP-1 is reshaping food supplements
3 August 2026
No Comments
Introduction The rapid rise of GLP‑1 therapies is redefining the weight management landscape, reopening
